Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$266,198
-$28,430 QoQ
Shares Held
2,107
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,742
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Advisors, LLC holds $18,785,727 across 8 Drug Manufacturers - General names. GILD ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,304 | $7,561,207 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,697 | $3,302,064 | |
| 3 | AMGN |
Amgen Inc
|
8,375 | $3,032,755 | |
| 4 | JNJ |
Johnson & Johnson
|
11,076 | $2,812,971 | |
| 5 | PFE |
Pfizer Inc
|
42,564 | $1,024,941 | |
| 6 | NVS |
Novartis AG
|
2,601 | $407,628 | |
| 7 | ABBV |
AbbVie Inc.
|
1,502 | $377,963 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,107 | $266,198 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,198 | 2,107 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $294,628 | 2,114 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $252,476 | 2,057 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $234,321 | 2,111 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $226,729 | 2,045 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $228,357 | 2,038 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||